Mark N. Lobato

Centers for Disease Control and Prevention
Federal Agency
Hartford, CT
USA
Email: mark.lobato@ct.gov

Papers:
Successes of 12 Weekly Doses of Isoniazid and Rifapentine As Treatment for Latent Tuberculosis Infection in Connecticut